AGT and cardiovascular disorder: AngII is a substrate of NEP, which degrades the peptide into two inactive products (Erdös and Skidgel, 1990), and thus, NEP inhibition might be anticipated to elevate plasma AngII concentrations, which could exacerbate cardiovascular diseases such as hypertension.